These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19020659)

  • 1. c-Myc is required for maintenance of glioma cancer stem cells.
    Wang J; Wang H; Li Z; Wu Q; Lathia JD; McLendon RE; Hjelmeland AB; Rich JN
    PLoS One; 2008; 3(11):e3769. PubMed ID: 19020659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
    Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain cancer stem cells display preferential sensitivity to Akt inhibition.
    Eyler CE; Foo WC; LaFiura KM; McLendon RE; Hjelmeland AB; Rich JN
    Stem Cells; 2008 Dec; 26(12):3027-36. PubMed ID: 18802038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.
    Patru C; Romao L; Varlet P; Coulombel L; Raponi E; Cadusseau J; Renault-Mihara F; Thirant C; Leonard N; Berhneim A; Mihalescu-Maingot M; Haiech J; Bièche I; Moura-Neto V; Daumas-Duport C; Junier MP; Chneiweiss H
    BMC Cancer; 2010 Feb; 10():66. PubMed ID: 20181261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive in vivo imaging of tumor-associated CD133/prominin.
    Tsurumi C; Esser N; Firat E; Gaedicke S; Follo M; Behe M; Elsässer-Beile U; Grosu AL; Graeser R; Niedermann G
    PLoS One; 2010 Dec; 5(12):e15605. PubMed ID: 21187924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells.
    Gil-Ranedo J; Mendiburu-Eliçabe M; García-Villanueva M; Medina D; del Álamo M; Izquierdo M
    PLoS One; 2011; 6(12):e28753. PubMed ID: 22174890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
    Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
    Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
    Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
    J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
    Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
    PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
    Arun S; Ravisankar S; Vanisree AJ
    J Neurooncol; 2017 Dec; 135(3):473-485. PubMed ID: 28875331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
    Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
    Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of glioma cancer stem cells.
    Park DM; Rich JN
    Mol Cells; 2009 Jul; 28(1):7-12. PubMed ID: 19655094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACYP2 contributes to malignant progression of glioma through promoting Ca
    Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.